Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Boeck

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Anti-epidermal growth factor receptor treatment strategies in advanced pancreatic cancer: success or failure?Stefan Boeck, Volker Heinemann
Future Oncology (London, England)|February 5, 2008
The role of second-line chemotherapy after gemcitabine failure in patients with advanced pancreatic cancerStefan Boeck, Volker Heinemann
Lancet (London, England)|August 30, 2017
Improving post-surgical management of resected pancreatic cancerStefan Boeck, Volker Heinemann
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancerStefan Boeck, Volker Heinemann
Annals of Surgery|February 7, 2022
Comment on: "Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis"Stefan Boeck, Volker Heinemann, Jens Werner
Cancer Treatment Reviews|January 10, 2012
Systemic treatment of advanced pancreatic cancerVolker Heinemann, Michael Haas, Stefan Boeck
Medizinische Klinik (Munich, Germany : 1983)|July 20, 2007
[Importance of neoadjuvant chemotherapy in gastrointestinal tumors. A new standard?]Nicolas Moosmann, Stefan Boeck, Volker Heinemann
Oncology|January 12, 2008
The role of adjuvant chemotherapy for patients with resected pancreatic cancer: systematic review of randomized controlled trials and meta-analysisStefan Boeck, Donna Pauler Ankerst, Volker Heinemann
Journal of Clinical Gastroenterology|March 18, 2008
Hemolytic-uremic syndrome associated with gemcitabine treatment for metastatic pancreatic cancerStefan Boeck, Sandra Geiger, Christoph Schulz, et al.
In Vivo (Athens, Greece)|November 16, 2014
Long-term progression-free survival in a metastatic pancreatic cancer patient treated with first-line nab-paclitaxel and gemcitabineStefan Boeck, Michael Haas, Stephan Kruger, et al.
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Anti-epidermal growth factor receptor treatment strategies in advanced pancreatic cancer: success or failure?Stefan Boeck, Volker Heinemann
Future Oncology (London, England)|February 5, 2008
The role of second-line chemotherapy after gemcitabine failure in patients with advanced pancreatic cancerStefan Boeck, Volker Heinemann
Lancet (London, England)|August 30, 2017
Improving post-surgical management of resected pancreatic cancerStefan Boeck, Volker Heinemann
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancerStefan Boeck, Volker Heinemann
Annals of Surgery|February 7, 2022
Comment on: "Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis"Stefan Boeck, Volker Heinemann, Jens Werner
Cancer Treatment Reviews|January 10, 2012
Systemic treatment of advanced pancreatic cancerVolker Heinemann, Michael Haas, Stefan Boeck
Medizinische Klinik (Munich, Germany : 1983)|July 20, 2007
[Importance of neoadjuvant chemotherapy in gastrointestinal tumors. A new standard?]Nicolas Moosmann, Stefan Boeck, Volker Heinemann
Oncology|January 12, 2008
The role of adjuvant chemotherapy for patients with resected pancreatic cancer: systematic review of randomized controlled trials and meta-analysisStefan Boeck, Donna Pauler Ankerst, Volker Heinemann
Journal of Clinical Gastroenterology|March 18, 2008
Hemolytic-uremic syndrome associated with gemcitabine treatment for metastatic pancreatic cancerStefan Boeck, Sandra Geiger, Christoph Schulz, et al.
In Vivo (Athens, Greece)|November 16, 2014
Long-term progression-free survival in a metastatic pancreatic cancer patient treated with first-line nab-paclitaxel and gemcitabineStefan Boeck, Michael Haas, Stephan Kruger, et al.
Pageof 14